The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Putilova T.A.

Ural Research Institute for Maternal and Infant Health

Dan´kova I.V.

Ural Research Institute for Maternal and Infant Health

Tretyakova T.B.

Ural Research Institute of Maternity and Infancy

Maternal obesity as risk factor for diabetic fetopathy in gestational diabetes mellitus

Authors:

Putilova T.A., Dan´kova I.V., Tretyakova T.B.

More about the authors

Read: 1410 times


To cite this article:

Putilova TA, Dan´kova IV, Tretyakova TB. Maternal obesity as risk factor for diabetic fetopathy in gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2024;24(1):19‑24. (In Russ.)
https://doi.org/10.17116/rosakush20242401119

Recommended articles:
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61
Chro­nic inflammation in case of obesity-associated diseases. Russian Journal of Preventive Medi­cine. 2025;(1):115-121
Identification of prognostic significant markers of early diagnosis of obesity and meta­bolic diso­rders. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):71-79

References:

  1. Ilovaiskaya IA. Influence of obesity in women on fertility and gestation. RMZh. 2016;1:32-37. (In Russ.).
  2. Ramonienė G, Maleckienė L, Nadišauskienė RJ, Bartusevičienė E, Railaitė DR, Mačiulevičienė R, Maleckas A. Maternal obesity and obstetric outcomes in a tertiary referral center. Medicina (Kaunas). 2017;53:2:109-113.  https://doi.org/10.1016/j.medici.2017.03.003
  3. Melchor I, Burgos J, Campo AD, Aiartzaguena A, Gutiérrez J, Melchor. Effect of maternal obesity on pregnancy outcomes in women delivering singleton babies: a historical cohort study. Nutrients.2019;27:47:6:625-630.  https://doi.org/10.1515/jpm-2019-0103
  4. Kapustin RV, Arzhanova ON, Bespalova ON, Pakin VS, Kiselev AG. The Role of obesity and overweight as a factor of gestational diabetes mellitus a systematic review. Zhurnal akusherstva i zhenskikh boleznei. 2015;5:87-96. (In Russ.).
  5. Rodrigo N, Saad S, Pollock C, Glastras SJ. Diet modification before or during pregnancy on maternal and foetal outcomes in rodent models of maternal obesity. 2022;21:14:10:2154. https://doi.org/10.3390/nu14102154
  6. Mishchenko OI, Kryukov PM, Moses KB, Mozes VG, Elgina MI, Rudaeva EV, Chernykh NS. Diabetic fetopathy — pathogenesis, prognosis, perinatal and neonatal outcomes. Mat’ i ditya v Kuzbasse. 2020;1:4-9. (In Russ.).
  7. Hua LL, Juan L, Ying YJ. Interactive affection of pre-pregnancy overweight or obesity, excessive gestational weight gain and glucose tolerance test characteristics on adverse pregnancy outcomes among women with gestational diabetes mellitus. Front Endocrinol (Lausanne). 2022;13:942271. https://doi.org/10.3389/fendo.2022.942271
  8. Blokhin NG, Shevchenko DM. Gestational diabetes mellitus. Arkhiv akusherstva i ginekologii im. V.F. Snegireva. 2017;4:2:61-67. (In Russ.). https://doi.org/10.18821/2313-8726-2017-4-2-61-67
  9. Chen Y, Wu Q, Zhang L, Chen D, Liang Z. Relationship of abnormal mid-term oral glucose tolerance test and maternal weight gain with adverse pregnancy outcomes in women with gestational diabetes mellitus. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50:3:313-319.  https://doi.org/10.3724/zdxbyxb-2020-0013
  10. Mustafa HJ, Seif K, Javinani A, Aghajani F, Orlinsky R. Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes. Am J Obstet Gynecol MFM. 2022;4:5:100682. https://doi.org/10.1016/j.ajogmf.2022.100682
  11. Halvorson KL, Vogt HB, Kightlinger L, Stevens D. The Impact of maternal diabetes, obesity and race on infant birth weights in South Dakota. S D Med. 2017;70:2:61-66. 
  12. Sun Y, Shen Z, Zhan Y, Wang Y. Effects of pre-pregnancy body mass index and gestational weight gain on maternal and infant complications. BMC Pregnancy Childbirth. 2020;6;20:1:390.  https://doi.org/10.1186/s12884-020-03071-y
  13. Skórzyńska-Dziduszko KE, Kimber-Trojnar Ż, Patro-Małysza J, Olszewska A. An Interplay between obesity and inflammation in gestational diabetes mellitus. Currt Pharmac Biotechnol. 2016;17:7:603-613.  https://doi.org/10.2174/1389201017666160127105926
  14. Demidova TYu, Ushanova FO. Pathophysiological aspects of the development of gestational diabetes mellitus. RMZh. Meditsinskoe obozrenie. 2019;3:10(II):86-89. (In Russ.).
  15. Solis-Paredes M, Estrada-Gutierrez G, Perichart-Perera O, Montoya-Estrada A, Guzmán-Huerta M, Borboa-Olivares H. Key clinical factors predicting adipokine and oxidative stress marker concentrations among normal, overweight and obese pregnant women using artificial neural networks. Int J Mol Sci. 2017:28;19:1:86.  https://doi.org/10.3390/ijms19010086
  16. Chabanova NB, Mataev SI, Vasil’kova TN, Troshina IA. Metabolic disorders in adipocytokine imbalance and gestational complications. Ozhirenie i metabolism. 2017;14:1:9-16. (In Russ.).
  17. Balachandiran M, Bobby Z, Dorairajan G, Gladwin V, Vinayagam V. Decreased maternal serum adiponectin and increased insulin-like growth factor-1 levels along with increased placental glucose transporter-1 expression in gestational diabetes mellitus: Possible role in fetal overgrowth. Placenta. 2021;104:71-80.  https://doi.org/10.1016/j.2020.11.008
  18. Tsiotra PC, Halvatsiotis P, Patsouras K. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus. Peptides. 2018;10:157-166.  https://doi.org/10.1016/j.placenta.2020.11.008
  19. Shang M, Dong X, Hou L. Correlation of adipokines and markers of oxidative stress in women with gestational diabetes mellitus and their newborns. J Obstet Gynaecol Res. 2018;44:4:637-646.  https://doi.org/10.1111/jog.13586
  20. Wijetunge S, Ratnayake R M C J, Kotakadeniya H M S R B, Rosairo S. Association between serum and adipose tissue resistin with dysglycemia in South Asian women. Nutr Diab. 2019;18;9:1:5.  https://doi.org/10.1038/s41387-019-0071-3
  21. Barnard SA, Pieters M, Lange ZD. The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels. Blood Rev. 2016;30:6:421-429.  https://doi.org/10.1016/j.blre.2016.05.002
  22. Avogaro A. Re: «Plasminogen activator inhibitor-1 and pericardial fat in individuals with type 2 diabetes mellitus» by Bayomi et al. Metab Syndr Relat Disord. 2017;15:6:266-268.  https://doi.org/10.1089/met.2017.0070
  23. Zorena K, Jachimowicz-Duda O, Ślęzak D. Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications. Int J Mol Sci. 2020;18:21:10:3570. https://doi.org/10.3390/ijms21103570
  24. Rozhkova OV, Remneva OV. Gestational diabetes mellitus: obstetric and perinatal aspects. ENI Zabaikal’skii meditsinskii vestnik. 2018;3:127-142. (In Russ.).
  25. Wang HQ, Lai HL, Li Y, Liu QF, Hu S, Li L. The Relationship between maternal gestational impaired glucose tolerance and risk of large-for-gestational-age infant: A meta-analysis. J Clin Res Pediatr Endocrinol. 2016;8:3:264-269.  https://doi.org/10.4274/jcrpe.2583
  26. Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ. 2016;354.  https://doi.org/10.1136/bmj.i4694
  27. Lysenko SN, Chechneva MA, Petrukhin VA, Burumkulova FF. Ultrasound diagnostics of diabetic fetopathy. Rossiiskii vestnik akushera-ginekologa. 2016;16:3:23-30. (In Russ.). https://doi.org/10.17116/rosakush201616323-30
  28. Remneva OV, Rozhkova OV, Trukhacheva NV, Brusentsov IG. Prognosis of diabetic fetopathy in gestational diabetes mellitus in the mother. Doktor.ru. 2020;19:6:45-49. (In Russ.). https://doi.org/10.31550/1727-2378-2020-19-6-45-49
  29. Kharitonova LA, Papysheva OV, Kataysh GA, Yudina TM, Bogomaz DS. The state of health of children born to mothers with diabetes. Rossiiskii vestnik perinatologii i pediatrii. 2018;3:26-31. (In Russ.).
  30. Blokhin NG, Shevchenko DM. Gestational diabetes mellitus. Arkhiv akusherstva i ginekologii imeni V.F. Snegireva. 2017;4:2. (In Russ.). https://doi.org/10.18821/2313-8726-2017-4-2-61-67
  31. Shmueli A, Salman L, Hadar E, Aviram A, Bardin R. Sonographic prediction of macrosomia in pregnancies complicated by maternal diabetes: finding the best formula. Arch Gynecol Obstet. 2019;299:1:97-103.  https://doi.org/10.1007/s00404-018-4934-y
  32. Dwyer VO, Russell NM, McDonnell B, Sharkey L, Mulcahy C, Higgins MF. Antenatal prediction of fetal macrosomia in pregnancies affected by maternal pre-gestational diabetes. J Matern Fetal Neonatal Med. 2022;35:25:7412-7416. https://doi.org/10.1080/14767058.2021.1949447
  33. Lowe WL Jr, Scholtens DM, Kuang A, Linder B, Lawrence JM, Lebenthal Y, McCance D, Hamilton J, Nodzenski M, Talbot O, Brickman WJ, Clayton P, Ma RC, Tam WH, Dyer AR, Catalano PM, Lowe LP, Metzger BE; HAPO Follow-up Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): Maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42:3:372-380.  https://doi.org/10.2337/dc18-1646
  34. Monteiro SS, Santos TS, Fonseca L, Saraiva M. Inappropriate gestational weight gain impact on maternofetal outcomes in gestational diabetes. Ann Med. 2023;55:1:207-214.  https://doi.org/10.1080/07853890.2022.2159063
  35. Josefson JL, Scholtens DM, Kuang A, Catalano PM, Lowe LP, Dyer AR, Petito LC, Lowe WL Jr, Metzger BE; HAPO Follow-up Study Cooperative Research Group. Newborn adiposity and cord blood C-peptide as mediators of the maternal metabolic environment and childhood adiposity. Diabetes Care. 2021;44:5:1194-1202. https://doi.org/10.2337/dc20-2398
  36. Chebanova NB, Vasil’kova TN, Mataev SI, Polyakova VA. The importance of obesity in fetal programming of chronic diseases. Sovremennye problemy nauki i obrazovaniya. 2017;2:26-29. (In Russ.).
  37. Dzgoeva FKh. Nutrition in the prenatal period of life: fetal programming of metabolic syndrome. Ozhirenie i metabolism. 2015;12:3:10-17. (In Russ.). https://doi.org/10.14341/omet2015310-17
  38. Wróblewski A, Strycharz J, Świderska E, Drewniak K. Molecular insight into the interaction between epigenetics and leptin in metabolic disorders. Nutrients. 2019;11:8:1872. https://doi.org/10.3390/nu11081872
  39. Gao W, Liu JL, Lu X, Yang Q. Epigenetic regulation of energy metabolism in obesity. J Mol Cell Biol. 2021;13:7:480-499.  https://doi.org/10.1093/jmcb/mjab043
  40. Ling C. Epigenetic regulation of insulin action and secretion — role in the pathogenesis of type 2 diabetes. J Intern Med. 2020;288:2:158-167.  https://doi.org/10.1111/joim.13049
  41. Wu FY, Yin RX. Recent progress in epigenetics of obesity. Diabetol Metab Syndr. 2022;17;14:1:171.  https://doi.org/10.1186/s13098-022-00947-1
  42. Drapkina OM, Kim OT. Epigenetics of obesity. Kardiovasculyarnaya terapiya i profilaktika. 2020;19:6:2632. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2632
  43. Levkovich MA, Plakhotya TG, Berdichevskaya EM, Tsaturyan LD. Features of cytokine regulation in chronic placental insufficiency. Sovremennye problemy nauki i obrazovaniya. 2016;4:18. 
  44. Shao SM, Tian HR. Neurodevelopmental outcomes of infants of diabetic mothers. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23:9:969-974.  https://doi.org/10.7499/j.issn.1008-8830.2106143
  45. Saber AM, Mohamed MA, Sadek AA, Mahmoud RA. Role of umbilical cord C-peptide levels in early prediction of hypoglycemia in infants of diabetic mothers. BMC Pediatr. 2021;17;21:1:85.  https://doi.org/10.1186/s12887-021-02547-w

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.